The cellular hematology of systemic lupus erythematosus

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 1019-1035

  Simantov, Ronit ^a   Laurence, Jeffrey ^a   Nachman, Ralph L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904030678     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50039-9     Document Type: Chapter

References (152)

1. E.M. Tan, A.S. Cohen, J.F. Fries, et al. (1982) Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 1271.
2. M.C. Hochberg (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 1725.
3. M. Pistiner, D.J. Wallace, S. Nessim, et al. (1991) Lupus erythematosus in the 1980s: A survey of 570 patients. Semin. Arthritis Rheum. 21 55.
4. J.C. Nossent and A.J. Swaak (1991) Prevalence and significance of hematologic abnormalities in patients with systemic lupus erythematosus. Q. J. Med. 80 605.
5. M. Michel, C. Johanet, O. Meyer, et al. (2001) Familial lupus erythematosus: Clinical and immunologic features of 125 multiplex families. Medicine 80 153.
6. D.S. Pisetsky, G. Gilkeson and E.W. St. Clair (1997) Systemic lupus erythematosus. Diagnosis and treatment. Med. Clin. North. Am. 81 113.
7. S.B. Krantz (1994) Pathogenesis and treatment of the anemia of chronic disease. Am. J. Med. Sci. 307 353.
8. A.D. Steinberg (1991) Systemic lupus erythematosus. Ann. Intern. Med. 115 548.
9. W.E. Jelkmann, J. Fandrey, S. Frede and H. Pagel (1994) Inhibiton of erythropoietin production by cytokines. Implications for the anemia in inflammatory states. Ann. N.Y. Acad. Sci. 718 300.
10. M.T. Bertero and F. Caligaris-Cappio (1997) Anemia of chronic disorders in systemic autoimmune diseases. Haemotologica 82 375.
11. C.G. Winearls, M.J. Pippard, C.D. Reid, et al. (1989) Characterization of the anemia of chronic renal disease and the mode of its correction by r-HuEPO. Q. J. Med. 70 113.
12. J.W. Esbach, J.L. Egrie, M.R. Downing, et al. (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med. 316 73.
13. S.B. Krantz (1995) Erythropoietin and the anemia of chronic disease. Nephrol. Dial. Transplant. 10(Suppl 2), 10.
14. H.R. Peeters, M. Jongen-Lavrencic, G. Vreugdenhil and A.J. Swaak (1996) Effect of recombinant erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: A randomised placebo controlled double blind 52 weeks clinical trial. Ann. Rheum. Dis. 55 739.
15. L.A. Hebert, D.J. Birmingham, X.P. Shen, J.T. Brandt, D.D. Sedmak and J.J. Dillon (1994) Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Am. J. Kidney Dis. 24 25.
16. R.T. Means Jr. (1994) Clinical applications of recombinant erythropoietin in the anemia of chronic disease. Hematol. Oncol. Clin. North Am. 8 933.
17. G. Schett, U. Firbas and W. Fureder (2001) Decreased serum erythropoietin levels and its relation to antierythropoietin antibodies in anaemia of systemic lupus erythematosus. Rheumatology 40 424.
18. M. Voulgarelis, S.I. Kokori, J.P. Ioannidis, A.G. Tzioufas, D. Kyriaki and H.M. Moutsopoulos (2000) Anaemia in systemic lupus erythematosus: Aetiological profile and the role of erythropoietin. Ann. Rheum. Dis. 59 217.
19. C. Finelli, G. Visan, B. Gamberi, et al. (1993) Steroid resistant acquired pure red cell aplasia. A partial remission induced by recombinant human erythropoietin. Br. J. Haematol. 83 28.
20. G.S. Habib, W.R. Saliba and P. Froom (2002) Pure red cell aplasia and lupus. Semin. Arthritis Rheum. 31 279.
21. P.D. Kiely, C.P. McGuckin, D.A. Collinns, D.H. Bevan and J.C. Marsh (1995) Erythrocyte aplasia and systemic lupus erythematosus. Lupus 4 407.
22. N. Casadevall, E. Dupuy, P. Mohlo-Sbatier, et al. (1996) Autoantibodies against human erythropoietin in a patient with pure red-cell aplasia. N. Engl. J. Med. 7 630.
23. C. Finelli, G. Visan, B. Gamberi, et al. (1993) Steroid resistant acquired pure red cell aplasia. A partial remission induced by recombinant human erythropoietin. Br. J. Haematol. 83 28.
24. Z.R. Zeigler, C.S. Rosenfeld and Shadduck (1993) Resolution of transfusion dependence by recombinant human erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia. Br. J. Haematol. 83 28.
25. H. Orbach, A. Ben-Yehuda, D. Ben-Yehuda, et al. (1995) Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin. J. Rheumatol. 22 2166.
26. A.M. Marmont (1991) Therapy of pure red cell aplasia. Semin. Hematol. 26 285.
27. Y. Ilan and Y. Naparstek (1993) Pure red cell aplasia associated with systemic lupus erythematosus: Remission after a single course of intravenous immunoglobulin. Acta Haematol. 89 152.
28. W.C. Koch, G. Massay, C.E. Russell, et al. (1990) Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J. Pediatr. 116 355.
29. S. Trapani, M. Ermini and F. Falcini (1999) Human parvovirus B19 infection: Its relationship with systemic lupus erythematosus. Semin. Arthritis Rheum. 28 319.
30. S.I. Kokori, J.P. Ioannidis, M. Voulgarelis, A.G. Tzioufas and H.M. Moutsopoulos (2000) Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am. J. Med. 108 198.
31. C.P. Engelfreit, M.A.M. Overbeeke and A.E.G.K.R. von dem Borne (1992) Autoimmune hemolytic anemia. Semin. Hematol. 29 3.
32. J.P. Leddy, J.L. Falany, G.E. Kissel, et al. (1993) Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J. Clin. Invest. 91 1672.
33. G.C.S. Oliviera, P.R. Hutchings, J.M. Roitt and P.M. Lydard (1994) Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin. Exp. Immunol. 96 297.
34. S. Nisitani, T. Tsubata, M. Murakami, et al. (1993) The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 178 1247.
35. M. Murukam, T. Tsubata, R. Shinkura, et al. (1994) Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180 111.
36. S. Nisitani, M. Masao and H. Tasuku (1997) Anti-red blood cell immunoglobulin transgenic mice: An experimental model of autoimmune hemolytic anemia. Ann. N. Y. Acad. Sci. 815 246.
37. D. Alarcon-Segovia, M. Deleze, C.V. Oria, et al. (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68 353.
38. J. Guzman, A.R. Cabral, J. Cabiedes, et al. (1994) Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia. Autoimmunity 18 51.
39. S. Kokori, J.P.A. Ionnidis, M. Voularelis, et al. (2000) Autoimmune hemolytic anemia in patient with systemic lupus erythematosus. Am. J. Med. 108 198.
40. L.F. Fries, C.M. Brickman and M.M. Frank (1983) Monocyte receptors for the Fc portion of IgG increase in number of autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J. Immunol. 131 1240.
41. J. Dacie (2001) The immune haemolytic anaemias: A century of exciting progress in understanding. Br. J. Haematol. 114 770.
42. D.T. Boumpas, G.P. Chrousos, R.L. Wilder, et al. (1993) Glucocorticoid therapy for immune-mediated diseases: Basic and Clinical Correlates. Ann. Intern. Med. 119 1198.
43. C. Hershko, M. Sonnenblick and J. Ashkenazi (1990) Control of steroid-resistant autoimmune hemolytic anemia by cyclosporin. Br. J. Haematol. 76 436.
44. J.M. Pignon, E. Poirson and H. Rochant (1993) Danazol in autoimmune hemolytic anemia. Br. J. Haematol. 83 343.
45. H. Von Keyserlingk, W. Meyer-Saballek, R. Arnzt, et al. (1987) Plasma exchange treatment in autoimmune hemolytic anemia of the warm antibody type with renal failure. Vox Sang 52 598.
46. G. Flores, C. Cunningham-Rundles, A.C. Newland and J.G. Bussel (1993) Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients. Am. J. Hematol. 44 237.
47. S. Perrotta, F. Locatelli, A. La Manna, et al. (2002) Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic aneamia in a patient with systemic lupus erythematosus. Br. J. Haematol. 116 465.
48. J.G. Pegels, F.M. Helmerhorst, E.F. van Leeuwen, et al. (1982) The Evans syndrome: Characterization of the responsible autoantibodies. Br. J. Haematol. 51 445.
49. P.A. Miescher, A. Tucci, P. Beris and H. Favre (1992) Autoimmune hemolytic anemia and/or thrombocytopenia associated with lupus parameters. Semin. Hematol. 29 13.
50. F. Le Deist, J.-F. Emile, F. Rieux-Laucat, et al. (1996) Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 348 719.
51. A. Scaradavou and J. Bussel (1995) Treatment of refractory Evans' syndrome with alternate-day cyclosporine and prednisone. J. Pediatr. Hematol. Oncol. 17 290.
52. S.A. Allard and J.T. Scott (1989) Systemic lupus erythematosus and acute intermittent porphyria. Br. J. Rheumatol. 28 254.
53. C. Camisa, M. Fox, Quillin. and J.P. Hibler (1995) Coexistence of subacute cutaneous lupus erythematosus and porphyria cutanea tarda: A case report. Cutis 56 101.
54. F.M. O'Reilly, S. O'Loughlin and G.M. Murphy (1996) Discoid lupus erythematosus and porphyria cutanea tarda. J. R. Soc. Med. 89 523.
55. S.A. Allard, P.J. Charles, A.L. Herrick, K.E. McColl and J.T. Scott (1990) Antinuclear antibodies and the diagnosis of systemic lupus erythematosus in patients with acute intermittent porphyria. Ann. Rheum. Dis. 49 246.
56. K. Nepveu and B. Libman (1996) Hepatitis C as another possible cause of porphyria cutanea tarda and systemic lupus erythematosus. Arthritis Rheum. 39 352.
57. A. Filiotou, G. Vaiopoulos, V. Capsimali, et al. (2002) Acute intermittent porphyria and systemic lupus erythematosus: Report of a case and review of the literature. Luous 11 190.
58. M. Abu-Shakra, M.B. Urowitz, D.D. Gladman and J. Gough (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J. Rheumatol. 22 1265.
59. J.D. Reveille, A. Bartolucci and G.S. Alarcon (1990) Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 33 37.
60. R.J. Cook, D.D. Gladman, D. Pericak and M.B. Urowitz (2000) Prediction of short-term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J. Rheumatol. 27 1892.
61. K.E. Moss, Y. Ioannou, S.M. Sultan, I. Haq and D.A. Isenberg (2002) Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann. Rheum. Dis. 61 409.
62. M.H. Miller, M.B. Urowitz and D.D. Gladman (1983) The significance of thrombocytopneia in systemic lupus erythematosus. Arthritis Rheum. 26 1181.
63. J.N. George, G.E. Raskob, S.R. Shah, M.A. Rizvi, S.A. Hamilton, S. Osborne and T. Vondracek (1998) Drug-induced thrombocytopenia: A systematic review of published case reports. Ann. Intern. Med. 129 886.
64. T.E. Warkentin and A. Greinacher (Eds) (2001) Heparin-Induced Thrombcytopenia New York: Dekker
65. M. Kuwana, J. Kaburaki and Y. Ikeda (1998) Autoreactive T cells to platelet GPIIb:GPIX in immune thrombocytopenic purpura. Role in production of antiplatelet autoantibody. J. Clin. Invest. 102 1393.
66. A.H. Lazarus, J. Ellis and J.W. Semple (2000) Comparison of platelet immunity in patients with SLE and with ITP. Transfus. Sci. 22 19.
67. P.E. Love and S.A. Santoro (1990) Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: Prevalence and clinical significance. Ann. Intern. Med. 112 682.
68. R. Simantov, J.M. LaSala, S.K. Lo, et al. (1995) Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96 2211.
69. D. Alarcon-Segovia, M. Deleze, C.V. Oria, J. Sanchez-Guerrero, L. Gomez-Pacheco, J. Cabiedes, L. Fernandez and S. Ponce de Leon (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68 353.
70. G. Sturfelt, O. Nived, R. Norberg, R. Thorstensson and K. Krook (1987) Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 30 382.
71. R. Stasi, E. Stipa, M. Masi, et al. (1996) Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 88 3354.
72. S. Karpatkin (1997) Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 349 1531.
73. C.A. Doan, B.A. Bouroncle and B.K. Wiseman (1960) Idiopathic and secondary thrombocytopenic purpura: Clinical study and evaluation of 381 cases over a period of 28 years. Ann. Intern. Med. 53 861.
74. Marcus, A.J. (1996). Platelet and their disorders. In “Disorders of Hemostasis” (O. D. Ratnoff, Ed.).
75. J.N. George, S.H. Woolf, G.E. Raskob, J.S. Wasser, L.M. Aledort, P.J. Ballem, V.S. Blanchette, J.B. Bussel, D.B. Cines, J.G. Kelton, A.E. Lichtin, R. McMillan, J.A. Okerbloom, D.H. Regan and I. Warner (1996) Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 3.
76. R. Stasi, E. Stipa, M. Masi, M. Cecconi, et al. (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am. J. Med. 98 436.
77. A. Julia, C. Araguas, J. Rossello, et al. (1990) Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 76 250.
78. W.R. Bell Jr. (2000) Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura. Semin. Hematol. 37(1 Suppl. 1), 22.
79. A.E. Park, G. Birgisson, M.J. Mastrangelo, M.J. Marcaccio and D.B. Witzke (2000) Laparoscopic splenectomy: Outcomes and lessons learned from over 200 cases. Surgery 128 660.
80. A. Scaradavou, B. Woo, B.M. Woloski, et al. (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 89 2689.
81. G. Emilia, M. Morselli and M. Luppi (2002) Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood 99 1482.
82. J. Anderson (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N. Engl. J. Med. 330 1560.
83. B. Godeau, J.-M. Zii, A. Schaeffer and P. Bierling (1995) High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids. Am. J. Hematol. 48 282.
84. Y.S. Ahn, W.J. Harrington, J.J. Byrnes, et al. (1978) The treatment of idiopathic thrombocytopenic purpura with vinbastine-loaded platelets. N. Engl. J. Med. 298 1101.
85. R. Stasi, A. Pagano, E. Stipa and S. Amadori (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98 952.
86. C. Arnal, J.C. Piette, J. Leone, et al. (2002) Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J. Rheumatol. 29 75.
87. F. Musio, E.M. Bohen, C.M. Yuan and P.G. Welch (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Arthritis Rheum. 28 1.
88. H.I. Brunner, M. Freedman and E.D. Silverman (1999) Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum. 42 2346.
89. G.G. Levy, W.C. Nichols, E.C. Lian, et al. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 488.
90. G. Remuzzi, M. Galbusera, M. Noris, et al. (2002) von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 100 778.
91. X. Zheng, D. Chung, T.K. Takayama, et al. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J. Biol. Chem. 276 41059.
92. M. Furlan, R. Robles, M. Solenthaler and B. Lammle (1998) Acquired deficiency of von Willebrand factorcleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91 2839.
93. T. Gungor, M. Furlan, B. Lammle, F. Kuhn and R.A. Seger (2001) Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus. Rheumatology 940.
94. D. Mitra, E.A. Jaffe, B. Weksler, et al. (1997) Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasma induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 89 1224.
95. J. Laurence and D. Mitra (1997) Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic sysdrome. Semin. Hematol. 34 98.
96. J.C. Moore, C.P. Hayward, T.E. Warkentin and J.G. Kelton (2001) Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 98 1842.
97. H. Mohri, S. Motomura, H. Kanamori, M. Matsuzaki, S. Watanabe, A. Maruta, F. Kodama and T. Okubo (1998) Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 91 3623.
98. J.F. Viallard, J.L. Pellegrin, C. Vergnes, A. Borel-Derlon, G. Clofent-Sanchez, A.T. Nurdan, B. Leng and P. Nurden (1997) Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus. Br. J. Haematol. 105 532.
99. F. Rodeghiero, G. Castaman and P.M. Mannucci (1991) Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev. 5 155.
100. O. Nived, G. Sturfelt and F. Wollheim (1985) Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group. Q. J. Med. 271
101. D.M. Keeling and D.A. Isenberg (1993) Haematological manifestations of systemic lupus erythematosus. Blood Rev. 7 199.
102. S. Kuster, S. Apenberg, K. Andrassy and E. Ritz (1992) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Contrib. Nephrol. 99 94.
103. M. Waldendorf and M. Schneider (1993) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 336 381.
104. S. Kuster, S. Apenberg, K. Andrassy and E. Ritz (1993) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 336 381.
105. S.N. Wong, V. Shah and M.J. Dillon (1995) Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. Eur. J. Pediatr. 154 43.
106. B.T. Kurien, J. Newland, C. Paczkowski, K.L. Moore and R.H. Scofield (2000) Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin. Exp. Immunol. 120 209.
107. M. Arenas, A. Abad, V. Valverde, et al. (1992) Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthrits Rheum. 35 979.
108. J.H. Liu, K. Ozaki, Y. Matsuzaki, et al. (1995) Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 100 480.
109. P.A. Courtney, A.D. Crockard, K. Williamson, A.E. Irvine, R.J. Kennedy and A.L. Bell (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 58 309.
110. A.P. Cairns, A.D. Crockard, J.R. McConnell, P.A. Courtney and A.L. Bell (2001) Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: Relations with apoptotic neutrophils and disease activity. Ann. Rheum. Dis. 60 950.
111. H.H. Euler, U.M. Schwab and J.O. Schroeder (1994) Filgrastim for lupus neutropenia. Lancet 344 1513.
112. G. Starkebaum (1997) Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease. Curr. Opin. Hematol. 4 196.
113. H. Wandt, M. Seifert, C. Falge and W.M. Gallmeier (1993) Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor. Ann. Hematol. 66 265.
114. H. Kondo, Y. Date, Y. Sakai and M. Akimoto (1994) Effective simultaneous rhG-CSF and methylprednisolone “pulse” therapy in agranulocytosis associated with systemic lupus erythematosus. Am. J. Hematol. 46 157.
115. H.H. Euler, P. Harten, R.A. Zeuner and U.M. Schwab (1997) Recombinant human granulocyte stimulating factor in patients with systemic lupus erythematosus associated with neutropenia and refractory infections. J. Rheumatol. 24 2153.
116. G. Starkebaum (2002) Chronic neutropenia associated with autoimmune disease. Semin. Hematol. 39 121.
117. M.W. Ward and S. Studenski (1990) Age-associated clinical manifestations of systemic lupus erythematosus: A multivariate regression analysis. J. Rheumatol. 17 476.
118. J.B. Harley, A.L. Sestak, L.G. Willis, S.M. Fu, J.A. Hansen and M. Reichlin (1989) A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum. 32 826.
119. C. Osman and A.J. Swaak (1994) Lymphocytotoxic antibodies in SLE: A review of the literature. Clin. Rheumatol. 13 21.
120. D.L. Greenwood, V.M. Gitlits, F. Alderuccio, et al. (2002) Autoantibodies in neuropsychiatric lupus. Autoimmunity 35 79.
121. J. Dhein, H. Walczak, C. Baumler, et al. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373 438.
122. T. Brunner, R.J. Mogil, D. La Face, N.J. Yoo, et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373 441.
123. K. Nagafuji, T. Shibuya, M. Harada, et al. (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86 883.
124. K. Yasutomo, H. Nagasawa, H. Hisaeda, et al. (1996) Fas system-mediated apoptosis suppresses lymphopoiesis. J. Immunol. 157 1981.
125. E. Gyimesi, M. Kavai, E. Kiss, et al. (1993) Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 94 140.
126. P. Blanco, A.K. Palucka, M. Gill, V. Pascual and J. Banchereau (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 1540.
127. H. Suzuki, H. Takemura and H. Kashiwagi (1995) Interleukin-1 receptor antagonist in patients with systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum. 38 1055.
128. L. Llorente, Y. Richard-Patin, J. Wijdenes, et al. (1993) Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 4 421.
129. B.K. Pelton, W. Hylton and A.M. Denman (1992) Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 89 251.
130. A. Yabuhara, F.C. Yang, T. Nakazawa, et al. (1996) A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J. Rheumatol. 23 171.
131. F. Erkeller-Yusel, F. Hulstaart, I. Hannet, D. Isenberg and P. Lydyard (1993) Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2 227.
132. T. Otsuka, K. Nagasawa, M. Harada and Y. Niho (1993) Bone marrow microenvironment of patients with systemic lupus erythematosus. J. Rheumatol. 20 967.
133. J.M. Hows (1990) Connective tissue disorders. I.W. Delamore, J.A. Liu Yin (Eds) haematologic Aspects of Systemic Disease London: Saunders
134. M. Morales-Polanco, F.J. Jimenez-Balderas and P. Yanez (1996) Storage histiocytes and hemophagocytosis: A common finding in the bone marrow of patients with active systemic lupus erythematosus. Arch. Med. Res. 57
135. R. Ramakrishna, P.W. Kyle, P.J. Day and A. Manohara (1995) Evans' syndrome, myelofibrosis and systemic lupus erythematosus: Role of procollagens in myelofibrosis. Pathology 27 255.
136. D. Foley-Nolan, M.F. Martin, D. Rowbotham, et al. (1992) Systemic lupus erythematosus presenting with myelofibrosis. J. Rheumatol. 19 1303.
137. R.L. Paquette, A. Meshkinpour and P.J. Rosen (1994) Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 73 145.
138. A. Aharon, Y. Levy, Y. Bar-Dayan, et al. (1997) Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 6 408.
139. S. Vasquez, A.F. Kavanaugh, N.R. Schneider, M.C. Wacholtz and P.E. Lipsky (1992) Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J. Rheumatol. 19 1625.
140. A. Winkler, R.W. Jackson, D.S. Kay, et al. (1988) Highdose intravenous cyclophosphamide treatment of systemic lupus erythematosus associated aplastic anemia. Arthritis Rheum. 31 693.
141. N. Frickhofen, J.P. Kaltwasser, H. Scherzenmeier, A. Raghavachar, et al. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methyprednisolone with or without cyclosporin. N. Engl. J. Med. 324 1297.
142. B. Speck (1991) Allogeneic bone marrow transplantation for severe aplastic anemia. Semin. Hematol. 28 319.
143. M.D. Eisner, J. Amory, B. Mullaney, et al. (1996) Necrotizing lymphadenitis associated with systemic lupus erythematosus. Semin. Arthritis Rheum. 26 477.
144. W.Y. Tsang and J.K. Chan (1994) Fine-needle aspiration cytologic diagnosis of Kikuchi's lymphadenitis. A report of 27 cases. Am. J. Clin. Pathol. 102 454.
145. K.M. el-Ramahi, A. Karrar and M.A. Ali (1994) Kikuchi disease and its association with systemic lupus erythematosus. Lupus 3 409.
146. S. Menon, M.L. Snaith and D. Isenberg (1993) The association of malignancy with SLE: An analysis of 150 patients under long-term review. Lupus 2 177.
147. M.J. Leandro and D.A. Isenberg (2001) Rheumatic diseases and malignancy—is there an association? Scand. J. Rheumatol. 30 185.
148. M. Abu-Ahakra, D.D. Gladman and M.B. Urowitz (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum. 39 1050.
149. L. Mellemkjaer, V. Andersen, M.S. Linet, et al. (1997) Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythemaotusus. Arthritis Rheum. 40 761.
150. J. Cibere, J. Sibley and M. Haga (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10 394.
151. S.M. Sultan, Y. Ioannou and D.A. Isenberg (2000) Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under longterm review. Rheumatology 39 1147.
152. Y. Xu and P.H. Wiernik (2001) Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus 10